or Try an Advanced Search...

    ETF Components for LABU - Direxion Daily S&P Biotech Bull 3X Shares


    Below is a list of stocks held by this ETF. We only list holdings in the same market. If this is a global ETF, there may be additional components other than those listed here.

    Holdings

    Symbol Grade Price % Change Allocation
    ALPN A 0.00 1.09
    RVMD B -1.11 0.79
    PTCT B -1.82 0.72
    GERN B 0.39 0.71
    MRNA B 0.56 0.71
    NTRA A -1.05 0.70
    VKTX B -2.27 0.70
    CRNX B 3.71 0.70
    UTHR A -1.42 0.69
    SRPT B -1.75 0.69
    NBIX B -1.47 0.68
    BPMC B -0.64 0.68
    CERE B -0.50 0.68
    AMGN B 1.35 0.67
    EXAS F -1.12 0.66
    ALNY D 0.27 0.66
    IONS F -0.99 0.65
    EXEL D -1.04 0.65
    RYTM D -2.87 0.65
    CYTK D -0.15 0.64
    BIIB C 0.50 0.64
    BMRN F 0.39 0.64
    DYN D -1.36 0.64
    VRTX C 3.38 0.64
    REGN C -0.83 0.62
    BBIO F -1.04 0.62
    HALO C 3.98 0.62
    TGTX C 1.80 0.62
    SWTX D -1.79 0.61
    INSM D -0.25 0.61
    KRYS D -0.68 0.61
    IDYA C -3.56 0.60
    ABBV D -1.30 0.60
    IRWD F -0.06 0.60
    DVAX D -0.34 0.59
    SNDX C -3.75 0.59
    IMVT F -1.12 0.59
    GILD F -0.37 0.58
    PCVX C 0.27 0.58
    INCY D -0.77 0.58
    VCEL C -2.72 0.58
    RARE F -0.69 0.57
    NVAX F -2.60 0.57
    FOLD F -0.87 0.56
    TWST B -3.27 0.56
    KYMR C -0.05 0.55
    NUVL D -1.23 0.55
    AGIO B -1.80 0.54
    ALKS F -1.83 0.54
    CLDX C -2.06 0.54
    MDGL D -5.28 0.54
    IOVA C -4.94 0.53
    VERA C -0.76 0.53
    CPRX D -1.85 0.53
    RCKT D -0.15 0.53
    BCRX D 0.19 0.52
    ARQT D 0.89 0.52
    DNLI F 14.01 0.51
    NTLA F -2.39 0.50
    KROS D 0.24 0.50
    INBX D -0.38 0.50
    ARDX C -2.79 0.50
    RXRX F -1.48 0.49
    MIRM F -1.78 0.49
    APLS F -4.51 0.49
    ACLX D -0.92 0.48
    ACAD F 0.00 0.48
    PRTA F -2.15 0.47
    ARWR F -0.44 0.46
    VCYT F -4.76 0.45
    ALT D 1.65 0.45
    CRSP F -2.68 0.45
    KURA C -1.76 0.45
    PTGX D 1.67 0.44
    MORF F -0.96 0.44
    AKRO F -2.45 0.43
    VRDN F 0.33 0.41
    XNCR B -1.90 0.40
    DCPH A -0.04 0.40
    BMEA F -4.42 0.40
    CCCC D 6.33 0.39
    MGNX D -9.66 0.39
    SAGE F -1.77 0.38
    RCUS F -2.54 0.38
    BEAM F -2.09 0.38
    SRRK D -0.61 0.37
    RNA B 1.58 0.37
    MYGN D 19.01 0.35
    COGT C -2.06 0.35
    SANA B -3.29 0.34
    ADMA A -1.30 0.33
    CABA F -3.77 0.32
    EDIT F -7.92 0.32
    ARCT F -1.02 0.31
    REPL F -1.45 0.30
    CDMO B -1.20 0.29
    ETNB F -2.99 0.29
    VIR D -2.32 0.28
    FDMT D -1.31 0.28
    TVTX F 1.19 0.26
    DAWN B -4.80 0.25
    CDNA C -0.38 0.24
    ZNTL F 0.57 0.24
    MNKD C -1.01 0.23
    SMMT A -0.94 0.22
    OLMA F -3.29 0.22
    RLAY F -2.00 0.22
    RGNX F -0.35 0.21
    IRON F -2.06 0.21
    FATE F -2.96 0.21
    CGEM B -2.93 0.20
    KNSA C -0.17 0.20
    NRIX C -0.49 0.20
    VERV F 1.46 0.19
    AVXL F -1.56 0.18
    ALLO F -2.84 0.17
    ANAB B 0.66 0.17
    MDXG D -0.89 0.15
    CRBU F -2.68 0.14
    ALEC F -1.32 0.10
    MRSN D -1.99 0.09
    VYGR D -0.80 0.07
    ORIC D 1.66 0.07
    SPRY C -1.16 0.07
    RCEL F -2.67 0.03

    Represented by ETF Holdings

    Keywords: Biopharmaceutical Biotechnology Medicine Cancer Life Sciences Clinical Medicine Biology Immune System Clinical Development Immunology Solid Tumors Disease Antibodies Organ Systems Monoclonal Antibodies Treatment Of Cancer Autoimmune Disease Monoclonal Antibody Enzymes Genetics
    Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Medical Devices

    Recent News for Direxion Daily S&P Biotech Bull 3X Shares & its Holdings

    Date Stock Title
    May 8 VRDN Viridian Therapeutics Inc (VRDN) Q1 2024 Earnings: Narrowing Losses Amidst Clinical Advancements
    May 8 KURA 2 Incredible Growth Stocks to Buy Hand Over Fist
    May 8 REGN Regeneron gene therapy improves hearing in child deafness
    May 8 BMRN BioMarin to Present at the BofA Securities 2024 Health Care Conference on Wednesday, May 15 at 10:00am PT / 1:00pm ET, in Las Vegas, NV
    May 8 ABBV QULIPTA™ (atogepant) Now Approved by Health Canada for the Preventive Treatment of Chronic Migraine in Adults
    May 8 IDYA IDEAYA Biosciences First Quarter 2024 Earnings: US$0.53 loss per share (vs US$0.49 loss in 1Q 2023)
    May 8 IONS Ionis Pharmaceuticals First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
    May 8 ZNTL Pleasing Signs As A Number Of Insiders Buy Zentalis Pharmaceuticals Stock
    May 8 KURA Kura Oncology to Participate in Bank of America Securities Healthcare Conference
    May 8 SNDX Syndax Pharmaceuticals GAAP EPS of -$0.85 beats by $0.12
    May 8 VRDN Viridian Therapeutics GAAP EPS of -$0.79 beats by $0.28, revenue of $0.07M misses by $0.01M
    May 8 SNDX Syndax Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Clinical and Business Update
    May 8 EDIT Editas Medicine GAAP EPS of -$0.76 misses by $0.18, revenue of $1.14M misses by $6.16M
    May 8 OLMA Olema Oncology Announces New Clinical Data for Palazestrant in Combination with Ribociclib to be Presented at the 2024 ESMO Breast Cancer Annual Congress
    May 8 BIIB Q1 2024 Abcellera Biologics Inc Earnings Call
    May 8 SWTX SpringWorks Therapeutics to Participate in the BofA Securities 2024 Health Care Conference
    May 8 KYMR Kymera Therapeutics to Participate in Upcoming May Investor Conferences
    May 8 VRDN Viridian Therapeutics Highlights Recent Progress and Reports First Quarter 2024 Financial Results
    May 8 EDIT Editas Medicine Announces First Quarter 2024 Results and Business Updates
    May 8 AKRO Akero Therapeutics to Present at the BofA Securities 2024 Health Care Conference
    The investment seeks daily investment results, of 300% of the performance of the S&P Biotechnology Select Industry Index ("index"). The index is provided by S&P and includes domestic companies from the biotechnology industry. The fund normally creates long positions by investing at least 80% of its assets in the securities that comprise the index and/or financial instruments that provide leveraged and unleveraged exposure to the index. These financial instruments include: swap agreements; options on securities and indices; forward contracts; reverse repurchase agreements; ETFs; and other financial instruments. The fund is non-diversified.
    Exchange Traded Fund ETF Exchange Traded Funds Index Fund Biotechnology Leveraged ETF Ultra ETF S&P 500 Index CBOE Repurchase Agreement Forward Contract
    Back to the Main LABU Page...